Abstract
Background
Obesity is a complex condition and a recognized public health challenge. Previous treatment options were associated with high failure rates, but recent trials have shown that significant weight loss can be achieved with GLP1-RAs. However, little is known about the patient’s experiences with GLP1-RAs.
Objectives
This paper systematically reviews research on patients’ experience with GLP1-RAs.
Methods
A literature search in PubMed, PsycINFO, Embase and Sociological Abstracts included studies on adults’ experiences with GLP1-RAs, regardless of methodology. Exclusions of studies: mental illness, pregnancy, former bariatric surgery, PCOS. Study quality and transparency were assessed according to design, using thematic analysis for synthesis.
Results
Nine studies, selected from 7,607 records, encompassed three qualitative studies (semi-structured interviews), three RCTs, two narrative reviews and one survey study. The analysis identified five key themes: (1) Patients are willing to accept adverse events, like gastrointestinal disorders, for successful weight loss, (2) Patients experience improved physical functioning, well-being, and active daily living as a result of weight loss, (3) Patients express diverse opinions and skills regarding the medication’s usability, (4) Patients believe that the medication improves their ability to manage sweet cravings, (5) Gender seems to affect patients’ experiences with the medication, with females reporting more benefits than males.
Conclusion
Despite a huge demand and usage of GLP1-RAs, qualitative research on patients’ experiences is scarce. Further studies are crucial for understanding short and long-term patient experiences.
Obesity is a complex condition and a recognized public health challenge. Previous treatment options were associated with high failure rates, but recent trials have shown that significant weight loss can be achieved with GLP1-RAs. However, little is known about the patient’s experiences with GLP1-RAs.
Objectives
This paper systematically reviews research on patients’ experience with GLP1-RAs.
Methods
A literature search in PubMed, PsycINFO, Embase and Sociological Abstracts included studies on adults’ experiences with GLP1-RAs, regardless of methodology. Exclusions of studies: mental illness, pregnancy, former bariatric surgery, PCOS. Study quality and transparency were assessed according to design, using thematic analysis for synthesis.
Results
Nine studies, selected from 7,607 records, encompassed three qualitative studies (semi-structured interviews), three RCTs, two narrative reviews and one survey study. The analysis identified five key themes: (1) Patients are willing to accept adverse events, like gastrointestinal disorders, for successful weight loss, (2) Patients experience improved physical functioning, well-being, and active daily living as a result of weight loss, (3) Patients express diverse opinions and skills regarding the medication’s usability, (4) Patients believe that the medication improves their ability to manage sweet cravings, (5) Gender seems to affect patients’ experiences with the medication, with females reporting more benefits than males.
Conclusion
Despite a huge demand and usage of GLP1-RAs, qualitative research on patients’ experiences is scarce. Further studies are crucial for understanding short and long-term patient experiences.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Scandinavian Journal of Primary Health Care |
| Antal sider | 10 |
| ISSN | 0281-3432 |
| DOI | |
| Status | E-pub ahead of print - 12 mar. 2025 |